Post-surgical recovery: why 47,000 deaths a year is a distribution problem

The scale of the demand

Approximately 50 million surgeries are performed in the United States each year (CDC National Hospital Discharge Survey). Post-surgical pain is the primary reason opioids are prescribed to previously opioid-naive patients. CDC data documents more than 80,000 overdose deaths annually, with prescription opioids remaining a significant contributor to the pipeline of dependence — particularly among patients who received their first opioid prescription after a surgical procedure. The demand for a non-narcotic recovery option is not manufactured; it is an active search behavior. Queries like 'recovery after knee replacement without opioids' and 'drug-free shoulder surgery recovery' represent high-intent, high-volume traffic with no satisfactory supply-side answer in the current market.

Who this patient is

The tPEMF post-surgical patient is not an early adopter or a wellness enthusiast. They are an orthopedic patient — knee replacement, hip replacement, rotator cuff repair, spinal fusion — who has been told to expect pain and handed a prescription for 30–60 narcotic tablets. They may have watched a family member struggle with opioid dependence. They are frightened of the pills, not the pain. They will research alternatives. They will find healwithout.com because they are searching for one. The willingness-to-pay is real: a patient who understands they can use pre-tax HSA dollars to pay for a $549 device sees a real out-of-pocket cost closer to $357–384. That is a compelling value proposition for three weeks of reduced pain and no opioid exposure.

The prescription gating problem

tPEMF is FDA Class II — it requires a physician's prescription. Most patients encounter the device online, post-discharge, when their surgeon is no longer accessible. They need a new Rx and — for HSA/FSA reimbursement — a Letter of Medical Necessity (LMN). Neither of these documents exists in the current patient journey. The altru.care async engine solves both: Josh Emdur, DO (licensed in all 50 states) reviews a brief intake and writes both the Rx and the LMN in 3–5 minutes, same day, without an office visit. The patient gets one checkout step, pre-tax pricing, and same-week device delivery.

• Class II prescription: required to dispense the device
• LMN: required for HSA/FSA pre-tax reimbursement (IRS 213(d))
• altru.care: async, same-day, 50-state — no office visit
• Effective patient cost: ~$357–384 with HSA at 30% marginal rate

Why the rep model can't reach this patient

The rep model operates B2B — rep visits surgeon, surgeon prescribes, patient receives. By definition, patients who arrive searching online after their surgery, without a prior prescription, cannot be served by this model. The surgeon has moved on. The device was never mentioned at discharge. The rep never met the patient. The DTC surface is the only mechanism that intercepts this demand where it actually forms — in the patient's living room, three days post-op, wondering if there's a better way.

The conversion moment

The conversion happens when two realizations arrive together: first, that a prescription-grade device exists with published evidence showing 57% lower pain and 2.2× less narcotic use; second, that the prescription path is same-day, no office visit, and the device qualifies for HSA pre-tax pricing. Neither realization alone closes the sale. The 57% result tells the patient the device works; the same-day async Rx tells them it's actually accessible. This page exists to deliver both in one visit — evidence first, then the clear path to getting it.

What this means in practice

A patient who uses tPEMF as an adjunct to their post-surgical protocol takes roughly half the opioids in the first 48 hours (p = 0.002), reports 57% lower pain at one hour, and enters the week-two recovery period with a lower opioid dependence exposure. They also go home with fewer pills in the medicine cabinet — a household safety consideration. The device runs on its own schedule through clothing or dressings, so there is no competing demand on a recovery period already full of wound care, physical therapy exercises, and medication management.